1364MO Preliminary phase II results of the CYPIDES study of ODM-208 in metastatic castration-resistant prostate (mCRPC) cancer patients

Autor: Fizazi, K., Bernard-Tessier, A., Barthelemy, P., Utriainen, T., Roubaud, G., Flechon, A., van der Voet, J.C.M., Gravis Mescam, G., Ratta, R., Jones, R.H., Parikh, O.A., Tanner, M.M.E., Garratt, C., Nevalaita, L., Pohjanjousi, P., Ikonen, T., Antonarakis, E.S., Cook, N.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S1165-S1165
Databáze: ScienceDirect